TUMORI, cilt.94, sa.6, ss.845-848, 2008 (SCI-Expanded)
Aims and background. Lung cancer is a leading cause of cancer death worldwide. However, despite recent advances in molecular biology that have revealed various genetic changes in lung cancer, the prognostic Outcome of lung cancer patients has improved only minimally. This Situation has changed fundamentally With the identification of molecular abnormalities that are characteristic of premalignant changes, Such as changes ill tumor suppressor genes, loss of heterozygosity at crucial sites, and activation of oncogenes. Inactivation of the tumor suppressor gene Fragile Histidine Triad (FHIT) is a frequent genetic change in lung cancer. The aim of this study was to identify FHIT-gene alterations in bronchoscopy specimens of patients with suspected lung cancer and to determine the molecular relevance, if any, of FHIT alterations in the development of cancer.